Tags : Acute Kidney Injury


Baxter Launches PrisMax Acute Care System for Acute Kidney Injury

Shots: Baxter has received the US FDA’s 510 (k) clearance for its PrisMax system and the integrated TherMax blood warmer for continuous renal replacement therapy (CRRT) and therapeutic plasma exchange (TPE) to treat patients with AKI and other immune diseases PrisMax features TrueVue Analytics tools evaluating the aggregated data, assessing the quality of CRRT program […]Read More


Baxter and BioMerieux Collaborates to Develop Biomarkers for Acute Kidney

Shots: Baxter and BioMerieux enter into an agreement to develop biomarkers for identification & treatment for acute kidney injury (AKI) The focus of the agreement is to utilize BioMerieux’s expertise in diagnostics & advancing Baxter’s critical care portfolio including nutrition, renal, hospital and surgical products  Additionally, On April 24, 2018 BioMerieux has acquired Astute Medical […]Read More